Causes of death in Prader-Willi syndrome: lessons from 11 years' experience of a national reference center.
Dibia Liz Pacoricona Alfaro, Perrine Lemoine, Virginie Ehlinger...
https://pubmed.ncbi.nlm.nih.gov/31684997/Actively Recruiting
Led by University Hospital, Toulouse · Updated on 2024-02-20
500
Participants Needed
1
Research Sites
52 weeks
Total Duration
Prader-Willi Syndrome PWS is a rare genetic condition affecting about 15 to 20,000 people at birth. It is a leading cause of genetic obesity and intellectual disabilities, causing severe physical, psychological, and social challenges. Due to the diseases complexity and severity, comprehensive multidisciplinary care is necessary, but many patients currently receive inadequate follow-up and management. There is limited information about the natural course of PWS and factors influencing its progression throughout life. This research aims to create a national register in France to track children and adults diagnosed with Prader-Willi Syndrome. The registry will collect data on clinical practices and their impact on patient health across all regions of the country. This observational study will follow patients over at least 10 years to better understand the diseases evolution and outcomes. Participants will provide baseline and ongoing data about their health and care, which will be gathered and analyzed to improve knowledge about PWS. The study involves data collection without administering treatments or interventions. Researchers will monitor patient information over time to assess health changes and support the development of improved care strategies. The total participation duration varies as data will be collected for a minimum of 10 years.
CONDITIONS
Register of Patients With Prader-Willi Syndrome
T
TAUBER Maité, MD PhD
M
MOLINAS Catherine, CRA
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital, Toulouse
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - At least 10 years
Participants with Prader-Willi Syndrome are observed over time to collect information about their health and clinical practices in various regions of France.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Dibia Liz Pacoricona Alfaro, Perrine Lemoine, Virginie Ehlinger...
https://pubmed.ncbi.nlm.nih.gov/31684997/University Hospital, Toulouse
Lead Sponsor